Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma
Mantle cell lymphoma (MCL) is an incurable B-cell non-Hodgkin lymphoma characterized by frequent relapses. The development of resistance to ibrutinib therapy remains a major challenge in MCL. We previously showed that glutaminolysis is associated with resistance to ibrutinib. In this study, we conf...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , , , , , , , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Ferrata Storti Foundation
2022-11-01
|
| মালা: | Haematologica |
| অনলাইন ব্যবহার করুন: | https://haematologica.org/article/view/10879 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
